The Status of Single Lung Lesion in Patients with History of Previous Malignancy: a Cross-sectional

来源 :第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 | 被引量 : 0次 | 上传用户:wk1990
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Objective: Defining the status of single lung lesion and making treatment strategy was intricate, and had been well studied for decades.However, seldom studies had focused on this issue in patients with history of previous malignancy.
其他文献
  目的:探讨支气管内超声引导针吸活检术(endobroncheal ultrasonography transbronchial needle aspiration,EBUS-TBNA)在肺、纵隔肿瘤中的诊断价值。方法:对2014年8月至201
  目的: Blocking the interaction between the programmed cell death (PD)-1 proteinand one of its ligands,PD-L1, has been reported to have impressive antitumor r
会议
  目的: Malignant pleuraleffusion (MPE) is mainly caused by metastatic pleuralcancer and defines malignant tumors with apoor prognosis.To achieve sufficient co
会议
  目的: Twist1 over expression has been reported to correspond with poorsurvival in non-small cell lung cancer (NSCLC), but the underlining mechanismis not clea
会议
  Objective: Along with the research progress of lung cancer-related driver genes, echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinas
会议
  Objective: Over the past decades, Lung cancer has located the first place of world-wide tumorigenic incidence and been the leading reason of death caused by
会议
  Objective: To observe the efficacy and safety of pulsatile administration of high-dose gefitinib or erlotinib for advanced non-small cell lung cancer patien
会议
  Objective: Small cell lung cancer (SCLC) is a refractory subtype of lung cancer characterized by limited drug responses, aggressive metastasis and relapse a
会议
  Objective: To investigate the effect of elemene on the radiosensitivity of A549 cells and its possible molecular mechanism.Method: The effect on cell radios
会议
  Objective: c-Met abnormalities can cause resistance to EGFR TKIs in EGFR mutant NSCLC patients (pts).The highly selective c-Met inhibitor tepotinib (MSC2156
会议